v3 Template
E

Emergent BioSolutions Inc.

Life Sciences / Public Health Gaithersburg, Md. and Basel, Switzerland ~440 employees
Founded
--
Employees (Est.)
~440
22 leaders known
Total Funding
$250.0M
Funding Rounds
1
Last Funding
2024-09-04

About Emergent BioSolutions Inc.

Emergent BioSolutions is a global specialty life sciences company focused on protecting and saving lives by delivering protective and life-saving solutions to communities worldwide. Their mission is to lead a new way forward for public health, addressing critical health threats and preparedness.

Products & Services

Commercial Products:Products addressing endemic public health threats such as the opioid epidemic.
Medical Countermeasures (MCM):Development, manufacturing, and supply of medical countermeasures for national security and public health preparedness.
Strategic Partnerships:Support for biopharma innovators, governments, and NGOs with development and manufacturing needs using specialized in-house capabilities.
NARCAN® Nasal Spray:A product highlighted in campaigns to address opioid emergencies.
TEMBEXA® (brincidofovir):An oral suspension antiviral for smallpox.
ACAM2000® (Smallpox and Mpox Vaccine, Live):A vaccine for smallpox and mpox supplied to the U.S. government.

Specialties

Medical Countermeasures Opioid Crisis Solutions Public Health Preparedness Biopharma Manufacturing Partnerships

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt
A: 250000000
MR: -
FA: $250 million
FAN: 250000000
D: 2024-09-04
FD: 2024-09-04
1 investors
Debt Latest
2024-09-04
$250.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jennifer W.

Director, Marketing Programs

J

Joseph Papa

President and Chief Executive Officer

R

Richard S. Lindahl

Executive Vice President, Chief Financial Officer, and Treasurer

C

Coleen Glessner

Executive Vice President Quality and Ethics and Compliance

S

Simon Lowry

Chief Medical Officer, Head of Research and Development

P

Paul Williams

Senior Vice President, Products Business

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

Emergent BioSolutions Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Life Sciences / Public Health
Company Size
~440 employees (est.)
Locations
Gaithersburg, Md. and Basel, Switzerland

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro